(Q40892650)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

title

Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies for Helicobacter pylori Strains Containing the gyrA Mutation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Hitoshi Tsugawa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Takanori Kanai

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

7

Kenro Hirata

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

10

Tatsuhiro Masaoka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

5

Seiichiro Fukuhara

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

6

Sawako Miyoshi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

8

Takashi Seino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

9

Misako Matsushita

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

Hideki Mori

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Hidekazu Suzuki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

1 reference

27 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

page(s)

286-294

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

1 March 2020

cites work

1 reference

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

21 January 2018

1 reference

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

21 January 2018

1 reference

Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance

21 January 2018

1 reference

Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin

21 January 2018

1 reference

Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.

21 January 2018

1 reference

Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance

21 January 2018

1 reference

Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies.

21 January 2018

1 reference

Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan

21 January 2018

1 reference

Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation

21 January 2018

1 reference

Efficacy of sitafloxacin-based rescue therapy for Helicobacter pylori after failures of first- and second-line therapies.

21 January 2018

1 reference

Multi-center randomized controlled study to establish the standard third-line regimen for Helicobacter pylori eradication in Japan

21 January 2018

1 reference

Gatifloxacin resistance and mutations in gyra after unsuccessful Helicobacter pylori eradication in Japan.

21 January 2018

1 reference

Dual therapy for third-line Helicobacter pylori eradication and urea breath test prediction

21 January 2018

1 reference

Homology model of the DNA gyrase enzyme of Helicobacter pylori, a target of quinolone-based eradication therapy.

21 January 2018

1 reference

Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.

21 January 2018

1 reference

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

21 January 2018

1 reference

Recombination and clonal groupings within Helicobacter pylori from different geographical regions.

21 January 2018

1 reference

How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

21 January 2018

1 reference

Molecular epidemiology, population genetics, and pathogenic role of Helicobacter pylori

21 January 2018

1 reference

'Rescue' therapies for the management of Helicobacter pylori infection

21 January 2018

1 reference

Helicobacter pylori eradication therapy

21 January 2018

1 reference

Antibiotic susceptibility of Helicobacter pylori in the Chinese population

21 January 2018

1 reference

Prevalence of antimicrobial resistance in Helicobacter pylori isolates in Taiwan in relation to consumption of antimicrobial agents

21 January 2018

1 reference

Antibiotic resistance in Helicobacter pylori strains and its effect on H. pylori eradication rates in a single center in Korea

21 January 2018

1 reference

Bactericidal and morphological effects of amoxicillin on Helicobacter pylori

21 January 2018

1 reference

Morphological and Bactericidal Effects of Different Antibiotics on Helicobacter pylori.

21 January 2018

1 reference

A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin

21 January 2018

1 reference

In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis

21 January 2018

1 reference

Molecular Detection of Helicobacter pylori and its Antimicrobial Resistance in Brazzaville, Congo

21 January 2018

1 reference

Spontaneous mutations that confer antibiotic resistance in Helicobacter pylori

21 January 2018

1 reference

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication

21 January 2018

1 reference

Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/HEL.12286

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26612407%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference